Anorectal Pressures and Simultaneous Dynamic Imaging

Overview

Información sobre este estudio

Many people have constipation because they cannot defecate. However, we do not fully understand the mechanisms of normal defecation or constipation. We are trying to better understand why constipation occurs and improve the tests for diagnosing these conditions.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria for Controls.

  • Healthy male (N=30) and female (N=30) volunteers aged 18-80 years.

  • Having capacity to provide written informed consent before participating in the study.

  • Able to communicate adequately with the investigator and to comply with the requirements for the entire study.

Inclusion Criteria for Constipated Patients.

  • Male and female volunteers aged 18-80 years.

  • Individuals with chronic constipation for 1 year, with 2 or more of the following symptoms for 3 months or longer: <3 bowel motions/week, straining ≥ 25% of time, hard or lumpy stools ≥ 25% of time, incomplete evacuation ≥ 25% of time, feeling of anorectal blockage ≥ 25% of time.

  • Having capacity to provide written informed consent before participating in the study.

  • Able to communicate adequately with the investigator and to comply with the requirements for the entire study.

 

Exclusion Criteria for Controls (Items indicated with an asterisk are also exclusion criteria for patients).

  • Clinical evidence of significant cardiovascular, respiratory, renal, hepatic, gastrointestinal, hematological, neurological, psychiatric or other disease that may interfere with the objectives of the study and/or pose safety concerns.*

  • Current symptoms of a functional gastrointestinal disorder assessed by questionnaire [2, 16].

  • Putative risk factors for pelvic floor trauma: i.e. six or more vaginal deliveries, birthweight >4500gms (macrosomia), or known 3rd or 4th degree perineal tear.

  • Medications that are likely to alter gastrointestinal motility: e.g., opiates, anticholinergic medications, serotoninergic agents, alpha adrenergic agonists, calcium channel or b blockers; a stable dose of thyroxine will be permitted (i.e. no alterations in dose for the preceding three months).

  • Active rectal inflammation, cancer; perianal sepsis; history of pelvic radiation, rectosigmoid surgery or inflammatory bowel disease.*

  • Anxiety or depression as assessed by the Hospital Anxiety and Depression Questionnaire [17].

  • Contraindications for MR imaging: i.e. pacemakers, aneurysm clips, cochlear implants.*

  • Pregnant women, prisoners and institutionalized individuals.*

     

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Adil Bharucha, M.B.B.S., M.D.

Abierto para la inscripción

Contact information:

Kelly Feuerhak R.N., CCRP

(507)255-6802

Feuerhak.Kelly@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20314944

Mayo Clinic Footer